Pfizer Pill Leads Race to Dominate $12 Billion Arthritis Market

Pfizer Inc., the world’s biggest drugmaker, leads a race against three rivals to sell the first new pill in a decade for rheumatoid arthritis, a joint disease treated by injected drugs with $12 billion in annual sales.
Bloomberg